Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD.

Laura Vilorio-MarquésChristelle Castañón FernándezElvira MoraLorena GutiérrezBeatriz Rey BuaMaria José Jiménez LorenzoMarina Díaz BeyaMiriam Vara PampliegaAntonieta MoleroJoaquín Sánchez-GarcíaMarisa CalabuigMaria Teresa CedenaTzu Chen-LiangJohana Alejandra Díaz SantaIrene PadillaFrancisca HernándezRosana DíezPedro AsensiBlanca XicoyGuillermo SanzDavid ValcárcelMaría Diez-CampeloTeresa Bernal Del Castillo

Published in: Therapeutic advances in hematology (2022)

HMA infectious toxicity worsens OS, hinders the adherence to antineoplastic treatment and results in significant morbidity. Preventive strategies are fundamental in vulnerable patients.

Keyphrases

acute myeloid leukemia
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
type diabetes
allogeneic hematopoietic stem cell transplantation
patient reported outcomes
adipose tissue
smoking cessation